Table 5.
Second validation: CORE risk score prediction for non-relapse mortality, overall survival, and relapse.
Score | Second Validation Cohort | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Pat. (%) | NRM | OS | Relapse | |||||||
HR (95% CI) | p (%) | 2-y (%) | HR (95% CI) | p (%) | 2-y (%) | HR (95% CI) | p (%) | 2-y (%) | ||
Total | 0.002 | <0.001 | 0.206 | |||||||
0–1 | 42 | reference | 7 | reference | 81 | reference | 25 | |||
2–4 | 50 | 3.08 (1.3–7.6) | 0.014 | 20 | 3.01 (1.7–5.4) | <0.001 | 55 | 1.61 (0.9–2.9) | 0.11 | 31 |
≥5 | 8 | 6.49 (2.1–19.7) | 0.001 | 43 * | 5.87 (2.6–13.1) | <0.001 | 30 * | 1.95 (0.7–5.7) | 0.22 | 31 * |
For the second validation cohort, n = 205; * data only available for day 717.